Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Terminated 1Recruiting 1Completed 1

Sponsor Class

OTHER 2NETWORK 1

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Breast 21Gastrointestinal 18Genitourinary 12Gynecologic 11CNS 8Other hematologic neoplasm 7Other solid neoplasm 4Lymphoid 4Head & Neck 3Sarcoma 2Dermatologic 2Tumor-Agnostic 1Thoracic 1Plasma cell 1Other neoplasm 1Myeloid 1Endocrine 1Classical hematology 1

Conditions

Head and Neck Neoplasms 2Urogenital Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Pheochromocytoma 1Paraganglioma 1Neoplastic Syndromes, Hereditary 1Neoplasms, Unknown Primary 1Kidney Neoplasms 1Digestive System Neoplasms 1Central Nervous System Neoplasms 1Breast Neoplasms 1Brain Neoplasms 1Bone Neoplasms 1

Interventions

Cisplatin 630Radiotherapy 339pembrolizumab 329Cetuximab 283Docetaxel 225Radiotherapy, Intensity-Modulated 221Fluorouracil 199Carboplatin 198Paclitaxel 161Nivolumab 145Gemcitabine 125Magnetic Resonance Spectroscopy 99Radiation 91Drug Therapy 86Capecitabine 76toripalimab 74Surveys and Questionnaires 73Surgical Procedures, Operative 72Biopsy 62durvalumab 61Chemoradiotherapy 52Blood Specimen Collection 52Cyclophosphamide 48Specimen Handling 47camrelizumab 46Radiosurgery 46Erlotinib Hydrochloride 46Standard of Care 43130-nm albumin-bound paclitaxel 43tislelizumab 42

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Genetic Testing × Head & Neck × Clear all
NCT03160274 2025-10-15

Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions

The University of Texas Health Science Center at San Antonio

Recruiting
2,000 enrolled
CNSEndocrineGenitourinaryHead & NeckSarcoma

Bone Neoplasms, Kidney Neoplasms, Neoplastic Syndromes, Hereditary, Paraganglioma, Pheochromocytoma, Thyroid Neoplasms

NCT04456140 2023-07-24

Pro-Active Genetic Testing in Patients With Solid Tumors, Inherit Study

Mayo Clinic

Phase 1 Completed
230 enrolled
BreastCNSGastrointestinalHead & Neck

Brain Neoplasms, Breast Neoplasms, Digestive System Neoplasms, Head and Neck Neoplasms, Neoplasms, Unknown Primary, Urogenital Neoplasms, Central Nervous System Neoplasms

NCT00646659 2018-07-09

Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By Surgery

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Terminated
47 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡